Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers

International Journal of Technology Assessment in Health Care
Andres Pichon-RiviereMichael Drummond

Abstract

HTA agencies, especially in developing countries, are under resourced and unable to conduct the desired amount of assessments. Adapting HTA reports (HTAs) from other jurisdictions is an alternative for saving resources. To explore HTA transferability experiences in Latin-America and Caribbean (LAC): are decision makers (DMs) using HTAs from other jurisdictions? Are researchers adapting HTAs when developing local reports? How useful is the information found in HTAs from other jurisdictions? Web-based survey sent to 13031 HTA researchers and DMs. We received 671 responses from 19 countries. DMs reported using HTAs from other jurisdictions to guide decisions in the majority of the situations: 52.6 percent HTAs from outside LAC (e.g., Europe), 23.1 percent from other LAC countries, and only 24.3 percent HTAs from their own countries. 63 percent of researchers reported using HTAs from other jurisdictions. Usefulness scored significantly higher for HTAs from other jurisdictions as compared to local HTAs (7.1 versus 6.0 in a 1-10 scale; p < .01). Both DMs and researchers considered the information regarding safety and effectiveness more applicable than the information on social aspects, or economic evaluation. Barriers that limit tran...Continue Reading

References

Nov 17, 2004·Health Technology Assessment : HTA·M J SculpherA Eastwood
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Oct 27, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Stephanie BoulengerGerard de Pouvourville
Apr 24, 2008·PharmacoEconomics·Mendel E Singer
Jul 12, 2008·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·John NixonGerard de Pouvourville
Jun 17, 2009·International Journal of Technology Assessment in Health Care·David Banta
Nov 6, 2009·PharmacoEconomics·Federico AugustovskiSebastián García Martí
Nov 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael DrummondJohan Severens
Dec 25, 2009·International Journal of Technology Assessment in Health Care·Sheila TurnerUNKNOWN European network for Health Technology Assessment (EUnetHTA)
Dec 25, 2009·International Journal of Technology Assessment in Health Care·Sheila TurnerUNKNOWN European network for Health Technology Assessment (EUnetHTA)
Jan 22, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Brigitte A B EssersManuela A Joore
Jul 30, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marco BarbieriUNKNOWN ISPOR Good Research Practices Economic Data Transferability Task Force
Oct 15, 2010·International Journal of Technology Assessment in Health Care·Andres Pichon-RiviereMichael F Drummond

❮ Previous
Next ❯

Citations

Nov 22, 2013·Pituitary·Marcello D BronsteinMoisés Mercado
Dec 4, 2014·Health Research Policy and Systems·Christine KrizaPeter L Kolominsky-Rabas
Feb 3, 2016·International Journal of Technology Assessment in Health Care·Michael DrummondSachin Kamal-Bahl
Jan 27, 2017·International Journal of Technology Assessment in Health Care·David HaileyElena Villamil
Mar 8, 2018·Journal of Medical Economics·Florian DamsMickaël Hiligsmann
May 19, 2020·Pharmacoepidemiology and Drug Safety·Maribel SalasUlf Bergman
Dec 20, 2017·Value in Health Regional Issues·Diego RosselliZoltán Kaló
Jul 20, 2021·Cost Effectiveness and Resource Allocation : C/E·Leticia García-MochónJaime Espin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Florian Turk
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Sean D Sullivan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Brigitte A B EssersManuela A Joore
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Marco BarbieriISPOR Good Research Practices Economic Data Transferability Task Force
© 2021 Meta ULC. All rights reserved